Berkeley, CA – According to filings with the U.S. Securities and Exchange Commission, Metagenomi Technologies is raising $27,273,177.00 in a new round of investment. Sources indicate as part of senior management Chief Executive Officer, Brian Thomas played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Metagenomi Technologies

Metagenomi is using the power of metagenomics to identify and characterize novel, naturally occurring genome editing systems, antibiotics and small molecules, and industrial enzymes for further development.

To learn more about Metagenomi Technologies, visit http://www.metagenomi.co/

Contact:
Brian Thomas, Chief Executive Officer
510-878-6868
https://www.linkedin.com/in/b-c-thomas/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved